Evolent Health, Inc. (EVH)
3.95
-0.15
(-3.66%)
USD |
NYSE |
Sep 15, 10:53
Evolent Health Enterprise Value : 1.294B for Sept. 14, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 1.294B |
| September 11, 2026 | 1.304B |
| September 10, 2026 | 1.302B |
| September 09, 2026 | 1.299B |
| September 08, 2026 | 1.307B |
| September 04, 2026 | 1.319B |
| September 03, 2026 | 1.312B |
| September 02, 2026 | 1.308B |
| September 01, 2026 | 1.314B |
| August 31, 2026 | 1.339B |
| August 28, 2026 | 1.350B |
| August 27, 2026 | 1.349B |
| August 26, 2026 | 1.386B |
| August 25, 2026 | 1.383B |
| August 24, 2026 | 1.364B |
| August 21, 2026 | 1.366B |
| August 20, 2026 | 1.361B |
| August 19, 2026 | 1.348B |
| August 18, 2026 | 1.348B |
| August 17, 2026 | 1.329B |
| August 14, 2026 | 1.359B |
| August 13, 2026 | 1.357B |
| August 12, 2026 | 1.302B |
| August 11, 2026 | 1.294B |
| August 10, 2026 | 1.275B |
| Date | Value |
|---|---|
| August 07, 2026 | 1.277B |
| August 06, 2026 | 1.236B |
| August 05, 2026 | 1.179B |
| August 04, 2026 | 1.182B |
| August 03, 2026 | 1.186B |
| July 31, 2026 | 1.180B |
| July 30, 2026 | 1.190B |
| July 29, 2026 | 1.204B |
| July 28, 2026 | 1.253B |
| July 27, 2026 | 1.261B |
| July 24, 2026 | 1.307B |
| July 23, 2026 | 1.355B |
| July 22, 2026 | 1.459B |
| July 21, 2026 | 1.491B |
| July 20, 2026 | 1.500B |
| July 17, 2026 | 1.486B |
| July 16, 2026 | 1.471B |
| July 15, 2026 | 1.493B |
| July 14, 2026 | 1.529B |
| July 13, 2026 | 1.499B |
| July 10, 2026 | 1.494B |
| July 09, 2026 | 1.466B |
| July 08, 2026 | 1.463B |
| July 07, 2026 | 1.449B |
| July 06, 2026 | 1.479B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DarioHealth Corp. | 70.21M |
| CompuMed, Inc. | 7.416M |
| Teladoc Health, Inc. | 1.443B |
| Renalytix Plc | -- |
| Lifestance Health Group, Inc. | 5.360B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -28.36M |
| Revenue (Quarterly) | 652.52M |
| Total Expenses (Quarterly) | 680.88M |
| EPS Diluted (Quarterly) | -0.252 |
| Gross Profit Margin (Quarterly) | 9.08% |
| Profit Margin (Quarterly) | -4.35% |
| Earnings Yield | -115.7% |
| Normalized Earnings Yield | -48.29 |